查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1856174

腎上腺皮質荷爾蒙原料藥：全球市佔率排名、總銷售額與需求預測（2025-2031年）

Adrenocortical Hormones API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球腎上腺皮質荷爾蒙原料藥市場規模預計為25.8億美元，預計到2031年將達到38.92億美元，在2025-2031年的預測期內，複合年成長率將達到6.2%。

原料藥腎上腺皮質荷爾蒙（API）是指用於生產皮質類固醇藥物的原料。這些荷爾蒙在腎上腺皮質合成，在調節新陳代謝、免疫反應和壓力適應方面發揮重要作用。常見的皮質腎上腺皮質荷爾蒙藥物成分包括Hydrocortisone可的松、潑尼松、地塞米松和Betamethasone，廣泛用於治療發炎性疾病、自體免疫疾病和內分泌功能障礙。這些活性原料藥的生產涉及複雜的化學合成或半合成過程，其原料為類固醇前體，通常來自植物固醇。由於其重要的醫療用途，腎上腺皮質荷爾蒙活性藥物成分必須經過嚴格的品管和監管，以確保其療效和安全性。

腎上腺皮質荷爾蒙製劑廣泛用於抗發炎、免疫抑制和內分泌疾病的治療，市場需求持續成長。歷史上，全球類固醇製藥業一直由輝瑞、拜耳、默克和賽諾菲等西方大型跨國製藥公司主導。這些公司擁有關鍵技術，並在高階市場佔據強大地位。然而，近年來，憑藉腎上腺皮質荷爾蒙。隨著製藥業的全球化進程不斷推進，類固醇供應鏈也不斷最佳化。中國製造商正積極推動產業升級和品管，推動產業走向更標準化和高附加價值。此外，更嚴格的環境法規和更高的生產標準也促使企業追求綠色生產和完善合規管理，進一步增強了中國在全球市場的競爭力。此外，全球人口老化和慢性病盛行率上升預計將持續推高對皮質類固醇製劑的需求，為該產業帶來更多成長機會。首先，腎上腺皮質荷爾蒙和化學合成技術的突破降低了生產成本，並增強了國際競爭力。其次，中國製造商在品管和國際認證方面取得了顯著進展，這有助於其進入歐美高階市場。此外，跨國製藥公司越來越依賴中國供應商來最佳化生產成本和供應鏈效率，加速了該產業向中國的轉移。全球環境法規的日益嚴格推高了部分製造商的營運成本。此外，國際貿易政策和智慧財產權保護的變化可能會影響中國企業的出口競爭力。而且，高階市場仍有技術壁壘，要求中國企業進一步投資核心專利、品牌影響力以及高級產品研發。

本報告旨在全面概述全球腎上腺皮質荷爾蒙原料藥市場，重點關注總銷售量、銷售收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用分析腎上腺皮質荷爾蒙原料藥。

腎上腺皮質荷爾蒙以銷售量（噸）和銷售收入（百萬美元）為單位，提供皮質類固醇原料藥市場規模、估算和預測，以2024年為基準年，並提供2020年至2031年的歷史數據和預測數據。定量和定性分析有助於讀者制定業務/成長策略、評估競爭格局、分析公司在當前市場中的地位，並就腎上腺皮質荷爾蒙原料藥做出明智的商業決策。

目錄

第1章 市場概覽

  • 腎上腺皮質荷爾蒙原料藥產品介紹
  • 全球腎上腺皮質荷爾蒙原料藥市場規模預測
  • 腎上腺皮質荷爾蒙原料藥市場趨勢及促進因素
  • 前提條件和限制條件
  • 調查目的
  • 多年的考慮

第2章 公司競爭分析

  • 全球腎上腺皮質荷爾蒙原料藥公司營收排名（2024 年）
  • 全球腎上腺皮質荷爾蒙原料藥收入（按公司分類）（2020-2025 年）
  • 全球腎上腺皮質荷爾蒙原料藥銷售額排名（2024 年）
  • 全球腎上腺皮質荷爾蒙原料藥銷售額（按公司分列）（2020-2025 年）
  • 全球腎上腺皮質荷爾蒙原料藥平均價格（按公司分類）（2020-2025 年）
  • 主要腎上腺皮質荷爾蒙原料藥製造地和總部
  • 主要生產商的腎上腺皮質荷爾蒙原料藥產品供應情況
  • 大型生產者何時開始大規模生產皮質腎上腺皮質荷爾蒙原料藥？
  • 腎上腺皮質荷爾蒙原料藥市場競爭分析
  • 併購、業務擴張

第3章 依類型細分

  • 按類型介紹
    • 潑尼松系列
    • 地塞米松系列
    • Betamethasone系列
    • Hydrocortisone系列
    • 其他
  • 全球腎上腺皮質荷爾蒙原料藥銷售額（按類型分類）
  • 全球腎上腺皮質荷爾蒙原料藥銷售量）
  • 全球腎上腺皮質荷爾蒙原料藥平均價格（按類型分類）（2020-2031 年）

第4章 按應用進行細分

  • 透過申請
    • 注射
    • 口服
    • 外用藥物
    • 吸入藥物
  • 全球腎上腺皮質荷爾蒙原料藥銷售額（按應用領域分類）
  • 全球腎上腺皮質荷爾蒙原料藥銷售量）
  • 全球腎上腺皮質荷爾蒙原料藥平均價格（按應用領域分類）（2020-2031 年）

第5章 區域細分

  • 全球腎上腺皮質荷爾蒙原料藥銷售額（按地區分類）
  • 全球腎上腺皮質荷爾蒙原料藥銷售量）
  • 全球腎上腺皮質荷爾蒙原料藥平均價格（按地區分類）（2020-2031 年）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第6章 按主要國家分類

  • 主要國家和地區腎上腺皮質荷爾蒙原料藥銷售額成長趨勢，2020 年、2024 年和 2031 年對比
  • 主要國家和地區腎上腺皮質荷爾蒙原料藥的銷售額和銷售量
  • 美國
  • 歐洲
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度

第7章 公司簡介

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong Vtr Bio-Tech
  • Zhejiang Xianju Xianle Pharmaceutical
  • TIANJIN PACIFIC PHARMACEUTICAL
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Saituo Biological Technology
  • Zhejiang Xianju Junye Pharmaceutical

第8章：產業鏈分析

第9章 研究結果與結論

第10章附錄

The global market for Adrenocortical Hormones API was estimated to be worth US$ 2580 million in 2024 and is forecast to a readjusted size of US$ 3892 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Adrenocortical hormones active pharmaceutical ingredients (APIs) refer to the raw materials used in the production of corticosteroid drugs. These hormones are synthesized in the adrenal cortex and play a crucial role in regulating metabolism, immune response, and stress adaptation. Common adrenocortical hormone APIs include hydrocortisone, prednisone, dexamethasone, and betamethasone, which are widely used in the treatment of inflammatory diseases, autoimmune disorders, and endocrine dysfunctions. The production of these APIs involves complex chemical synthesis or semi-synthetic processes derived from steroid precursors, often sourced from plant sterols. Due to their essential medical applications, adrenocortical hormone APIs are subject to strict quality control and regulatory compliance to ensure their efficacy and safety.

Adrenocortical hormone drugs are widely used for anti-inflammatory, immunosuppressive, and endocrine disease treatments, with stable and growing market demand. Historically, the global steroid drug industry has been dominated by major multinational pharmaceutical companies from Europe and the United States, such as Pfizer, Bayer, Merck, and Sanofi. These companies hold key technologies and have a strong presence in high-end markets. However, in recent years, China has emerged as a major production hub for steroid drugs due to its advantages in raw material supply, lower production costs, and continuous improvements in manufacturing technology. As a result, China has become an increasingly significant player in the global adrenocortical hormone API market.As the pharmaceutical industry continues to globalize, the supply chain for steroid drugs is becoming more optimized. Chinese manufacturers are advancing in industrial upgrading and quality control, driving the sector towards greater standardization and higher value-added products. Additionally, stricter environmental regulations and improved production standards are pushing companies toward green manufacturing and better compliance management, further strengthening China's competitiveness in the global market. Moreover, rising aging populations and increasing prevalence of chronic diseases worldwide are expected to sustain demand for adrenocortical hormone drugs, creating further growth opportunities for the industry.Several factors are driving the industry's growth. Firstly, breakthroughs in fermentation and chemical synthesis technologies have lowered production costs, enhancing global competitiveness. Secondly, Chinese manufacturers have made significant progress in quality control and international certifications, enabling easier entry into high-end markets in Europe and the United States. Additionally, multinational pharmaceutical companies are increasingly relying on Chinese suppliers to optimize their production costs and supply chain efficiency, accelerating the industry's shift toward China.However, the industry also faces challenges. Stricter environmental regulations worldwide are increasing operational costs for some manufacturers. Additionally, changes in international trade policies and intellectual property rights protection could impact Chinese companies' export competitiveness. Furthermore, technical barriers in high-end markets remain, requiring Chinese companies to further invest in core patents, brand influence, and premium product development.

This report aims to provide a comprehensive presentation of the global market for Adrenocortical Hormones API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Adrenocortical Hormones API by region & country, by Type, and by Application.

The Adrenocortical Hormones API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adrenocortical Hormones API.

Market Segmentation

By Company

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong Vtr Bio-Tech
  • Zhejiang Xianju Xianle Pharmaceutical
  • TIANJIN PACIFIC PHARMACEUTICAL
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Saituo Biological Technology
  • Zhejiang Xianju Junye Pharmaceutical

Segment by Type

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Segment by Application

  • Injectable Drugs
  • Oral Drugs
  • Topical Drugs
  • Inhaled Drugs

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Adrenocortical Hormones API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Adrenocortical Hormones API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Adrenocortical Hormones API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Adrenocortical Hormones API Product Introduction
  • 1.2 Global Adrenocortical Hormones API Market Size Forecast
    • 1.2.1 Global Adrenocortical Hormones API Sales Value (2020-2031)
    • 1.2.2 Global Adrenocortical Hormones API Sales Volume (2020-2031)
    • 1.2.3 Global Adrenocortical Hormones API Sales Price (2020-2031)
  • 1.3 Adrenocortical Hormones API Market Trends & Drivers
    • 1.3.1 Adrenocortical Hormones API Industry Trends
    • 1.3.2 Adrenocortical Hormones API Market Drivers & Opportunity
    • 1.3.3 Adrenocortical Hormones API Market Challenges
    • 1.3.4 Adrenocortical Hormones API Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Adrenocortical Hormones API Players Revenue Ranking (2024)
  • 2.2 Global Adrenocortical Hormones API Revenue by Company (2020-2025)
  • 2.3 Global Adrenocortical Hormones API Players Sales Volume Ranking (2024)
  • 2.4 Global Adrenocortical Hormones API Sales Volume by Company Players (2020-2025)
  • 2.5 Global Adrenocortical Hormones API Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Adrenocortical Hormones API Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Adrenocortical Hormones API Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Adrenocortical Hormones API
  • 2.9 Adrenocortical Hormones API Market Competitive Analysis
    • 2.9.1 Adrenocortical Hormones API Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Adrenocortical Hormones API Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Prednisone Series
    • 3.1.2 Dexamethasone Series
    • 3.1.3 Betamethasone Series
    • 3.1.4 Hydrocortisone Series
    • 3.1.5 Others
  • 3.2 Global Adrenocortical Hormones API Sales Value by Type
    • 3.2.1 Global Adrenocortical Hormones API Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Adrenocortical Hormones API Sales Value, by Type (2020-2031)
    • 3.2.3 Global Adrenocortical Hormones API Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Adrenocortical Hormones API Sales Volume by Type
    • 3.3.1 Global Adrenocortical Hormones API Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Adrenocortical Hormones API Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Adrenocortical Hormones API Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Adrenocortical Hormones API Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Injectable Drugs
    • 4.1.2 Oral Drugs
    • 4.1.3 Topical Drugs
    • 4.1.4 Inhaled Drugs
  • 4.2 Global Adrenocortical Hormones API Sales Value by Application
    • 4.2.1 Global Adrenocortical Hormones API Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Adrenocortical Hormones API Sales Value, by Application (2020-2031)
    • 4.2.3 Global Adrenocortical Hormones API Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Adrenocortical Hormones API Sales Volume by Application
    • 4.3.1 Global Adrenocortical Hormones API Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Adrenocortical Hormones API Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Adrenocortical Hormones API Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Adrenocortical Hormones API Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Adrenocortical Hormones API Sales Value by Region
    • 5.1.1 Global Adrenocortical Hormones API Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Adrenocortical Hormones API Sales Value by Region (2020-2025)
    • 5.1.3 Global Adrenocortical Hormones API Sales Value by Region (2026-2031)
    • 5.1.4 Global Adrenocortical Hormones API Sales Value by Region (%), (2020-2031)
  • 5.2 Global Adrenocortical Hormones API Sales Volume by Region
    • 5.2.1 Global Adrenocortical Hormones API Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Adrenocortical Hormones API Sales Volume by Region (2020-2025)
    • 5.2.3 Global Adrenocortical Hormones API Sales Volume by Region (2026-2031)
    • 5.2.4 Global Adrenocortical Hormones API Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Adrenocortical Hormones API Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.4.2 North America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.5.2 Europe Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Adrenocortical Hormones API Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.7.2 South America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Adrenocortical Hormones API Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Adrenocortical Hormones API Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Adrenocortical Hormones API Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.3.2 United States Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.4.2 Europe Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.5.2 China Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.6.2 Japan Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.7.2 South Korea Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.9.2 India Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Pfizer CentreOne
    • 7.1.1 Pfizer CentreOne Company Information
    • 7.1.2 Pfizer CentreOne Introduction and Business Overview
    • 7.1.3 Pfizer CentreOne Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Pfizer CentreOne Adrenocortical Hormones API Product Offerings
    • 7.1.5 Pfizer CentreOne Recent Development
  • 7.2 EUROAPI
    • 7.2.1 EUROAPI Company Information
    • 7.2.2 EUROAPI Introduction and Business Overview
    • 7.2.3 EUROAPI Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 EUROAPI Adrenocortical Hormones API Product Offerings
    • 7.2.5 EUROAPI Recent Development
  • 7.3 GlaxoSmithKline
    • 7.3.1 GlaxoSmithKline Company Information
    • 7.3.2 GlaxoSmithKline Introduction and Business Overview
    • 7.3.3 GlaxoSmithKline Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 GlaxoSmithKline Adrenocortical Hormones API Product Offerings
    • 7.3.5 GlaxoSmithKline Recent Development
  • 7.4 Teva Pharmaceutical Industries
    • 7.4.1 Teva Pharmaceutical Industries Company Information
    • 7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
    • 7.4.3 Teva Pharmaceutical Industries Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Teva Pharmaceutical Industries Adrenocortical Hormones API Product Offerings
    • 7.4.5 Teva Pharmaceutical Industries Recent Development
  • 7.5 Hovione
    • 7.5.1 Hovione Company Information
    • 7.5.2 Hovione Introduction and Business Overview
    • 7.5.3 Hovione Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hovione Adrenocortical Hormones API Product Offerings
    • 7.5.5 Hovione Recent Development
  • 7.6 Axplora
    • 7.6.1 Axplora Company Information
    • 7.6.2 Axplora Introduction and Business Overview
    • 7.6.3 Axplora Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Axplora Adrenocortical Hormones API Product Offerings
    • 7.6.5 Axplora Recent Development
  • 7.7 Steroid SpA
    • 7.7.1 Steroid SpA Company Information
    • 7.7.2 Steroid SpA Introduction and Business Overview
    • 7.7.3 Steroid SpA Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Steroid SpA Adrenocortical Hormones API Product Offerings
    • 7.7.5 Steroid SpA Recent Development
  • 7.8 Avik Pharmaceutical
    • 7.8.1 Avik Pharmaceutical Company Information
    • 7.8.2 Avik Pharmaceutical Introduction and Business Overview
    • 7.8.3 Avik Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Avik Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.8.5 Avik Pharmaceutical Recent Development
  • 7.9 Anuh Pharma
    • 7.9.1 Anuh Pharma Company Information
    • 7.9.2 Anuh Pharma Introduction and Business Overview
    • 7.9.3 Anuh Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Anuh Pharma Adrenocortical Hormones API Product Offerings
    • 7.9.5 Anuh Pharma Recent Development
  • 7.10 Symbiotec Pharmalab
    • 7.10.1 Symbiotec Pharmalab Company Information
    • 7.10.2 Symbiotec Pharmalab Introduction and Business Overview
    • 7.10.3 Symbiotec Pharmalab Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Symbiotec Pharmalab Adrenocortical Hormones API Product Offerings
    • 7.10.5 Symbiotec Pharmalab Recent Development
  • 7.11 Sun Pharmaceutical
    • 7.11.1 Sun Pharmaceutical Company Information
    • 7.11.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.11.3 Sun Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Sun Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.11.5 Sun Pharmaceutical Recent Development
  • 7.12 Cipla
    • 7.12.1 Cipla Company Information
    • 7.12.2 Cipla Introduction and Business Overview
    • 7.12.3 Cipla Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Cipla Adrenocortical Hormones API Product Offerings
    • 7.12.5 Cipla Recent Development
  • 7.13 Wellona Pharma
    • 7.13.1 Wellona Pharma Company Information
    • 7.13.2 Wellona Pharma Introduction and Business Overview
    • 7.13.3 Wellona Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Wellona Pharma Adrenocortical Hormones API Product Offerings
    • 7.13.5 Wellona Pharma Recent Development
  • 7.14 Tianjin Tianyao Pharmaceuticals
    • 7.14.1 Tianjin Tianyao Pharmaceuticals Company Information
    • 7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
    • 7.14.3 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Offerings
    • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development
  • 7.15 Zhejiang Xianju Pharmaceutical
    • 7.15.1 Zhejiang Xianju Pharmaceutical Company Information
    • 7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
    • 7.15.3 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Development
  • 7.16 Guangdong Vtr Bio-Tech
    • 7.16.1 Guangdong Vtr Bio-Tech Company Information
    • 7.16.2 Guangdong Vtr Bio-Tech Introduction and Business Overview
    • 7.16.3 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Offerings
    • 7.16.5 Guangdong Vtr Bio-Tech Recent Development
  • 7.17 Zhejiang Xianju Xianle Pharmaceutical
    • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
    • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
    • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • 7.18 TIANJIN PACIFIC PHARMACEUTICAL
    • 7.18.1 TIANJIN PACIFIC PHARMACEUTICAL Company Information
    • 7.18.2 TIANJIN PACIFIC PHARMACEUTICAL Introduction and Business Overview
    • 7.18.3 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Offerings
    • 7.18.5 TIANJIN PACIFIC PHARMACEUTICAL Recent Development
  • 7.19 Shandong Xinhua Pharmaceutica Group
    • 7.19.1 Shandong Xinhua Pharmaceutica Group Company Information
    • 7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
    • 7.19.3 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Offerings
    • 7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development
  • 7.20 Jiangsu Lianhuan Pharmaceutical
    • 7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
    • 7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
    • 7.20.3 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development
  • 7.21 Shanghai New Hualian Pharmaceutical
    • 7.21.1 Shanghai New Hualian Pharmaceutical Company Information
    • 7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview
    • 7.21.3 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.21.5 Shanghai New Hualian Pharmaceutical Recent Development
  • 7.22 Shandong Taihua Biotech
    • 7.22.1 Shandong Taihua Biotech Company Information
    • 7.22.2 Shandong Taihua Biotech Introduction and Business Overview
    • 7.22.3 Shandong Taihua Biotech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 Shandong Taihua Biotech Adrenocortical Hormones API Product Offerings
    • 7.22.5 Shandong Taihua Biotech Recent Development
  • 7.23 Saituo Biological Technology
    • 7.23.1 Saituo Biological Technology Company Information
    • 7.23.2 Saituo Biological Technology Introduction and Business Overview
    • 7.23.3 Saituo Biological Technology Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 Saituo Biological Technology Adrenocortical Hormones API Product Offerings
    • 7.23.5 Saituo Biological Technology Recent Development
  • 7.24 Zhejiang Xianju Junye Pharmaceutical
    • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
    • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
    • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Adrenocortical Hormones API Industrial Chain
  • 8.2 Adrenocortical Hormones API Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Adrenocortical Hormones API Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Adrenocortical Hormones API Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Adrenocortical Hormones API Market Trends
  • Table 2. Adrenocortical Hormones API Market Drivers & Opportunity
  • Table 3. Adrenocortical Hormones API Market Challenges
  • Table 4. Adrenocortical Hormones API Market Restraints
  • Table 5. Global Adrenocortical Hormones API Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Adrenocortical Hormones API Revenue Market Share by Company (2020-2025)
  • Table 7. Global Adrenocortical Hormones API Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Adrenocortical Hormones API Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Adrenocortical Hormones API Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Adrenocortical Hormones API Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Adrenocortical Hormones API Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Adrenocortical Hormones API
  • Table 13. Global Adrenocortical Hormones API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Adrenocortical Hormones API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Adrenocortical Hormones API Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Adrenocortical Hormones API Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Adrenocortical Hormones API Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Adrenocortical Hormones API Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Adrenocortical Hormones API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Adrenocortical Hormones API Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Adrenocortical Hormones API Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Adrenocortical Hormones API Sales Volume Market Share by Type (2020-2025)
  • Table 25. Global Adrenocortical Hormones API Sales Volume Market Share by Type (2026-2031)
  • Table 26. Global Adrenocortical Hormones API Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Adrenocortical Hormones API Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Adrenocortical Hormones API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Adrenocortical Hormones API Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Adrenocortical Hormones API Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Adrenocortical Hormones API Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Adrenocortical Hormones API Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Adrenocortical Hormones API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Adrenocortical Hormones API Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Adrenocortical Hormones API Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Adrenocortical Hormones API Sales Volume Market Share by Application (2020-2025)
  • Table 37. Global Adrenocortical Hormones API Sales Volume Market Share by Application (2026-2031)
  • Table 38. Global Adrenocortical Hormones API Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Adrenocortical Hormones API Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Adrenocortical Hormones API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Adrenocortical Hormones API Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Adrenocortical Hormones API Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Adrenocortical Hormones API Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Adrenocortical Hormones API Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Adrenocortical Hormones API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Adrenocortical Hormones API Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Adrenocortical Hormones API Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Adrenocortical Hormones API Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Adrenocortical Hormones API Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Adrenocortical Hormones API Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Adrenocortical Hormones API Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Adrenocortical Hormones API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Adrenocortical Hormones API Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Adrenocortical Hormones API Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Adrenocortical Hormones API Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Adrenocortical Hormones API Sales Volume, (2026-2031) & (Tons)
  • Table 57. Pfizer CentreOne Company Information
  • Table 58. Pfizer CentreOne Introduction and Business Overview
  • Table 59. Pfizer CentreOne Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Pfizer CentreOne Adrenocortical Hormones API Product Offerings
  • Table 61. Pfizer CentreOne Recent Development
  • Table 62. EUROAPI Company Information
  • Table 63. EUROAPI Introduction and Business Overview
  • Table 64. EUROAPI Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. EUROAPI Adrenocortical Hormones API Product Offerings
  • Table 66. EUROAPI Recent Development
  • Table 67. GlaxoSmithKline Company Information
  • Table 68. GlaxoSmithKline Introduction and Business Overview
  • Table 69. GlaxoSmithKline Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. GlaxoSmithKline Adrenocortical Hormones API Product Offerings
  • Table 71. GlaxoSmithKline Recent Development
  • Table 72. Teva Pharmaceutical Industries Company Information
  • Table 73. Teva Pharmaceutical Industries Introduction and Business Overview
  • Table 74. Teva Pharmaceutical Industries Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Teva Pharmaceutical Industries Adrenocortical Hormones API Product Offerings
  • Table 76. Teva Pharmaceutical Industries Recent Development
  • Table 77. Hovione Company Information
  • Table 78. Hovione Introduction and Business Overview
  • Table 79. Hovione Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. Hovione Adrenocortical Hormones API Product Offerings
  • Table 81. Hovione Recent Development
  • Table 82. Axplora Company Information
  • Table 83. Axplora Introduction and Business Overview
  • Table 84. Axplora Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Axplora Adrenocortical Hormones API Product Offerings
  • Table 86. Axplora Recent Development
  • Table 87. Steroid SpA Company Information
  • Table 88. Steroid SpA Introduction and Business Overview
  • Table 89. Steroid SpA Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 90. Steroid SpA Adrenocortical Hormones API Product Offerings
  • Table 91. Steroid SpA Recent Development
  • Table 92. Avik Pharmaceutical Company Information
  • Table 93. Avik Pharmaceutical Introduction and Business Overview
  • Table 94. Avik Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 95. Avik Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 96. Avik Pharmaceutical Recent Development
  • Table 97. Anuh Pharma Company Information
  • Table 98. Anuh Pharma Introduction and Business Overview
  • Table 99. Anuh Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 100. Anuh Pharma Adrenocortical Hormones API Product Offerings
  • Table 101. Anuh Pharma Recent Development
  • Table 102. Symbiotec Pharmalab Company Information
  • Table 103. Symbiotec Pharmalab Introduction and Business Overview
  • Table 104. Symbiotec Pharmalab Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 105. Symbiotec Pharmalab Adrenocortical Hormones API Product Offerings
  • Table 106. Symbiotec Pharmalab Recent Development
  • Table 107. Sun Pharmaceutical Company Information
  • Table 108. Sun Pharmaceutical Introduction and Business Overview
  • Table 109. Sun Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 110. Sun Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 111. Sun Pharmaceutical Recent Development
  • Table 112. Cipla Company Information
  • Table 113. Cipla Introduction and Business Overview
  • Table 114. Cipla Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 115. Cipla Adrenocortical Hormones API Product Offerings
  • Table 116. Cipla Recent Development
  • Table 117. Wellona Pharma Company Information
  • Table 118. Wellona Pharma Introduction and Business Overview
  • Table 119. Wellona Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 120. Wellona Pharma Adrenocortical Hormones API Product Offerings
  • Table 121. Wellona Pharma Recent Development
  • Table 122. Tianjin Tianyao Pharmaceuticals Company Information
  • Table 123. Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
  • Table 124. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 125. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Offerings
  • Table 126. Tianjin Tianyao Pharmaceuticals Recent Development
  • Table 127. Zhejiang Xianju Pharmaceutical Company Information
  • Table 128. Zhejiang Xianju Pharmaceutical Introduction and Business Overview
  • Table 129. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 130. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 131. Zhejiang Xianju Pharmaceutical Recent Development
  • Table 132. Guangdong Vtr Bio-Tech Company Information
  • Table 133. Guangdong Vtr Bio-Tech Introduction and Business Overview
  • Table 134. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 135. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Offerings
  • Table 136. Guangdong Vtr Bio-Tech Recent Development
  • Table 137. Zhejiang Xianju Xianle Pharmaceutical Company Information
  • Table 138. Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
  • Table 139. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 140. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 141. Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • Table 142. TIANJIN PACIFIC PHARMACEUTICAL Company Information
  • Table 143. TIANJIN PACIFIC PHARMACEUTICAL Introduction and Business Overview
  • Table 144. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 145. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Offerings
  • Table 146. TIANJIN PACIFIC PHARMACEUTICAL Recent Development
  • Table 147. Shandong Xinhua Pharmaceutica Group Company Information
  • Table 148. Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
  • Table 149. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 150. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Offerings
  • Table 151. Shandong Xinhua Pharmaceutica Group Recent Development
  • Table 152. Jiangsu Lianhuan Pharmaceutical Company Information
  • Table 153. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
  • Table 154. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 155. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 156. Jiangsu Lianhuan Pharmaceutical Recent Development
  • Table 157. Shanghai New Hualian Pharmaceutical Company Information
  • Table 158. Shanghai New Hualian Pharmaceutical Introduction and Business Overview
  • Table 159. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 160. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 161. Shanghai New Hualian Pharmaceutical Recent Development
  • Table 162. Shandong Taihua Biotech Company Information
  • Table 163. Shandong Taihua Biotech Introduction and Business Overview
  • Table 164. Shandong Taihua Biotech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 165. Shandong Taihua Biotech Adrenocortical Hormones API Product Offerings
  • Table 166. Shandong Taihua Biotech Recent Development
  • Table 167. Saituo Biological Technology Company Information
  • Table 168. Saituo Biological Technology Introduction and Business Overview
  • Table 169. Saituo Biological Technology Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 170. Saituo Biological Technology Adrenocortical Hormones API Product Offerings
  • Table 171. Saituo Biological Technology Recent Development
  • Table 172. Zhejiang Xianju Junye Pharmaceutical Company Information
  • Table 173. Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
  • Table 174. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 175. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 176. Zhejiang Xianju Junye Pharmaceutical Recent Development
  • Table 177. Key Raw Materials Lists
  • Table 178. Raw Materials Key Suppliers Lists
  • Table 179. Adrenocortical Hormones API Downstream Customers
  • Table 180. Adrenocortical Hormones API Distributors List
  • Table 181. Research Programs/Design for This Report
  • Table 182. Key Data Information from Secondary Sources
  • Table 183. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Adrenocortical Hormones API Product Picture
  • Figure 2. Global Adrenocortical Hormones API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Adrenocortical Hormones API Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Adrenocortical Hormones API Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Adrenocortical Hormones API Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Adrenocortical Hormones API Report Years Considered
  • Figure 7. Global Adrenocortical Hormones API Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Adrenocortical Hormones API Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Adrenocortical Hormones API Revenue in 2024
  • Figure 10. Adrenocortical Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Prednisone Series Picture
  • Figure 12. Dexamethasone Series Picture
  • Figure 13. Betamethasone Series Picture
  • Figure 14. Hydrocortisone Series Picture
  • Figure 15. Others Picture
  • Figure 16. Global Adrenocortical Hormones API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Adrenocortical Hormones API Sales Value Market Share by Type, 2024 & 2031
  • Figure 18. Global Adrenocortical Hormones API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 19. Global Adrenocortical Hormones API Sales Volume Market Share by Type, 2024 & 2031
  • Figure 20. Global Adrenocortical Hormones API Price by Type (2020-2031) & (US$/kg)
  • Figure 21. Product Picture of Injectable Drugs
  • Figure 22. Product Picture of Oral Drugs
  • Figure 23. Product Picture of Topical Drugs
  • Figure 24. Product Picture of Inhaled Drugs
  • Figure 25. Global Adrenocortical Hormones API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 26. Global Adrenocortical Hormones API Sales Value Market Share by Application, 2024 & 2031
  • Figure 27. Global Adrenocortical Hormones API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 28. Global Adrenocortical Hormones API Sales Volume Market Share by Application, 2024 & 2031
  • Figure 29. Global Adrenocortical Hormones API Price by Application (2020-2031) & (US$/kg)
  • Figure 30. North America Adrenocortical Hormones API Sales Value (2020-2031) & (US$ Million)
  • Figure 31. North America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Europe Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Asia Pacific Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Asia Pacific Adrenocortical Hormones API Sales Value by Region (%), 2024 VS 2031
  • Figure 36. South America Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. South America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Middle East & Africa Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Middle East & Africa Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 40. Key Countries/Regions Adrenocortical Hormones API Sales Value (%), (2020-2031)
  • Figure 41. Key Countries/Regions Adrenocortical Hormones API Sales Volume (%), (2020-2031)
  • Figure 42. United States Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. United States Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 44. United States Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Europe Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Europe Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Europe Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 48. China Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. China Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 50. China Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Japan Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. Japan Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 53. Japan Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 54. South Korea Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. South Korea Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 56. South Korea Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 57. Southeast Asia Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. Southeast Asia Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 59. Southeast Asia Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 60. India Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 61. India Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 62. India Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 63. Adrenocortical Hormones API Industrial Chain
  • Figure 64. Adrenocortical Hormones API Manufacturing Cost Structure
  • Figure 65. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed